|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Impairment of intangible assets | |||||
| Impairment | |||||
| Provision for credit losses | |||||
| Deferred income tax provision | |||||
| Stock-based compensation expense | |||||
| Net loss (gain) on life insurance policies and deferred compensation plan assets | |||||
| Other | |||||
| Changes in operating assets and liabilities (excluding effect of businesses acquired): | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Acquisitions, net of cash acquired | |||||
| Purchases of property, plant and equipment | |||||
| Proceeds from sales of property, plant and equipment | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Net short-term debt borrowings | |||||
| Proceeds from long-term debt borrowings | |||||
| Principal payments on long-term debt | |||||
| Cash dividends and dividend equivalents | |||||
| Share repurchases | |||||
| Taxes paid related to net share settlement of restricted stock units | |||||
| Excise tax on repurchase of common shares | |||||
| Other | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Decrease in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning balance | |||||
| Cash and cash equivalents, ending balance | |||||
| Supplemental cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid, net | |||||
Loading...